Jury awards $752 million in dispute over cutting-edge CAR-T technology
The California case was one of the early patent battles over the breakthrough cancer cell therapy technology, which is set to become a crowded space in years to come.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.